These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32194366)

  • 1. Uric Acid as a Potential Peripheral Biomarker for Disease Features in Huntington's Patients.
    Corey-Bloom J; Haque A; Aboufadel S; Snell C; Fischer RS; Granger SW; Granger DA; Thomas EA
    Front Neurosci; 2020; 14():73. PubMed ID: 32194366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levels of Interleukin-6 in Saliva, but Not Plasma, Correlate with Clinical Metrics in Huntington's Disease Patients and Healthy Control Subjects.
    Corey-Bloom J; Fischer RS; Kim A; Snell C; Parkin GM; Granger DA; Granger SW; Thomas EA
    Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32887270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Biochemical and Epigenetic Measures of Peripheral Brain-Derived Neurotrophic Factor (BDNF) as a Biomarker in Huntington's Disease Patients.
    Gutierrez A; Corey-Bloom J; Thomas EA; Desplats P
    Front Mol Neurosci; 2019; 12():335. PubMed ID: 32038165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.
    Tabrizi SJ; Reilmann R; Roos RA; Durr A; Leavitt B; Owen G; Jones R; Johnson H; Craufurd D; Hicks SL; Kennard C; Landwehrmeyer B; Stout JC; Borowsky B; Scahill RI; Frost C; Langbehn DR;
    Lancet Neurol; 2012 Jan; 11(1):42-53. PubMed ID: 22137354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Blood Glial Fibrillary Acidic Protein as a Potential Marker in Huntington's Disease.
    You H; Wu T; Du G; Huang Y; Zeng Y; Lin L; Chen D; Wu C; Li X; Burgunder JM; Pei Z
    Front Neurol; 2021; 12():779890. PubMed ID: 34867769
    [No Abstract]   [Full Text] [Related]  

  • 6. Salivary levels of total huntingtin are elevated in Huntington's disease patients.
    Corey-Bloom J; Haque AS; Park S; Nathan AS; Baker RW; Thomas EA
    Sci Rep; 2018 May; 8(1):7371. PubMed ID: 29743609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between uric acid levels and Huntington's disease progression.
    Auinger P; Kieburtz K; McDermott MP
    Mov Disord; 2010 Jan; 25(2):224-8. PubMed ID: 20063429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early grey matter changes in structural covariance networks in Huntington's disease.
    Coppen EM; van der Grond J; Hafkemeijer A; Rombouts SA; Roos RA
    Neuroimage Clin; 2016; 12():806-814. PubMed ID: 27830113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver function in Huntington's disease assessed by blood biochemical analyses in a clinical setting.
    Nielsen SM; Vinther-Jensen T; Nielsen JE; Nørremølle A; Hasholt L; Hjermind LE; Josefsen K
    J Neurol Sci; 2016 Mar; 362():326-32. PubMed ID: 26944172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tongue force analysis assesses motor phenotype in premanifest and symptomatic Huntington's disease.
    Reilmann R; Bohlen S; Klopstock T; Bender A; Weindl A; Saemann P; Auer DP; Ringelstein EB; Lange HW
    Mov Disord; 2010 Oct; 25(13):2195-202. PubMed ID: 20645403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tau or neurofilament light-Which is the more suitable biomarker for Huntington's disease?
    Niemelä V; Landtblom AM; Blennow K; Sundblom J
    PLoS One; 2017; 12(2):e0172762. PubMed ID: 28241046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of native and non-urate Total Antioxidant Capacity of fasting plasma and saliva among middle-aged and older subjects.
    Gawron-Skarbek A; Prymont-Przymińska A; Sobczak A; Guligowska A; Kostka T; Nowak D; Szatko F
    Redox Rep; 2018 Dec; 23(1):57-62. PubMed ID: 29088986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortical inhibitory deficits in premanifest and early Huntington's disease.
    Philpott AL; Cummins TDR; Bailey NW; Churchyard A; Fitzgerald PB; Georgiou-Karistianis N
    Behav Brain Res; 2016 Jan; 296():311-317. PubMed ID: 26416671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissociation between decision-making under risk and decision-making under ambiguity in premanifest and manifest Huntington's disease.
    Adjeroud N; Besnard J; Verny C; Prundean A; Scherer C; Gohier B; Bonneau D; Massioui NE; Allain P
    Neuropsychologia; 2017 Aug; 103():87-95. PubMed ID: 28712946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum uric acid levels in patients with Parkinson's disease: their relationship to treatment and disease duration.
    Andreadou E; Nikolaou C; Gournaras F; Rentzos M; Boufidou F; Tsoutsou A; Zournas C; Zissimopoulos V; Vassilopoulos D
    Clin Neurol Neurosurg; 2009 Nov; 111(9):724-8. PubMed ID: 19632030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic and hormonal signatures in pre-manifest and manifest Huntington's disease patients.
    Wang R; Ross CA; Cai H; Cong WN; Daimon CM; Carlson OD; Egan JM; Siddiqui S; Maudsley S; Martin B
    Front Physiol; 2014; 5():231. PubMed ID: 25002850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients?
    Moccia M; Picillo M; Erro R; Vitale C; Longo K; Amboni M; Santangelo G; Spina E; De Rosa A; De Michele G; Santoro L; Barone P; Pellecchia MT
    Parkinsonism Relat Disord; 2014 Jul; 20(7):772-5. PubMed ID: 24725754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-invasive determination of uric acid in human saliva in the diagnosis of serious disorders.
    Vernerová A; Kujovská Krčmová L; Melichar B; Švec F
    Clin Chem Lab Med; 2021 Apr; 59(5):797-812. PubMed ID: 33554551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benton Judgment of Line Orientation (JoLO) Test: A Brief and Useful Measure for Assessing Visuospatial Abilities in Manifest, but not Premanifest, Huntington's Disease.
    Corey-Bloom J; Gluhm S; Herndon A; Haque AS; Park S; Gilbert PE
    J Huntingtons Dis; 2016; 5(1):91-6. PubMed ID: 27003664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum uric acid in patients with Parkinson's disease and vascular parkinsonism: a cross-sectional study.
    Pan M; Gao H; Long L; Xu Y; Liu M; Zou J; Wu A; Wei X; Chen X; Tang B; Wang Q
    Neuroimmunomodulation; 2013; 20(1):19-28. PubMed ID: 23154271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.